Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
794.00    4.00 (0.51%)
Bid:
774.00
Ask:
780.00
Spread: 6.00 (0.775%)
Market Cap: £366.00m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close Trading Update and Acquisition

8 Dec 2017 07:00

RNS Number : 7434Y
Porvair PLC
08 December 2017
 

For immediate release 8 December 2017

 

 

Porvair PLC

 

Pre-close trading update and acquisition

 

Porvair plc ("Porvair", "the Group" or "the Company"), the specialist filtration and environmental technologies group, announces the following trading update and acquisition ahead of its close period for the year ended 30 November 2017.

Trading update

Revenue growth for the year ended 30 November 2017 was 6%. Underlying revenue(1) growth was 11% overall, with underlying revenue growth of 13% in the Microfiltration division and 1% in the Metals Filtration division. Earnings for the year are forecast to be ahead of management's expectations.

Net cash at the 30 November 2017 was £9.7 million (2016: £13.6 million), after capital and acquisition expenditure of approximately £11 million. Group order books for the start of the 2018 financial year are healthy. 

New divisional structure

Recognising the Group's growth in recent years, and as noted in the 2017 interim report, the Board will change the Group's management and reporting structure in 2018 to one that offers better management and market focus and greater investor clarity. The 2017 Report and Accounts will use the current two division structure, but will include proforma information for the new three new divisions, which will serve distinct markets: Aerospace & Industrial; Laboratory; and Molten Metals.

Acquisition

The new Laboratory division, which will focus on filtration and sample preparation products, acquired Rohasys B.V., a Dutch company, on 7 December 2017. This small acquisition brings robotic sample handling expertise to the division, which will enhance the Group's growing bioscience sample preparation capabilities.

Date of preliminary announcement

Porvair will announce its preliminary results for the year ended 30 November 2017 on Monday 29 January 2018.

Market Abuse Regime

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

Note (1) Underlying revenue: Revenue at constant currency excluding the impact of large projects.

 

For further information, please contact:

Porvair plc

 

01553 765 500

Ben Stocks, Chief Executive

 

 

Chris Tyler, Group Finance Director

 

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, separation and environmental technologies businesses. Its products are used in a range of niche filtration and separation markets, and are derived from its expertise in the design and manufacture of filtration and separation systems. From the 2018 financial year it is organised into three divisions: Aerospace & Industrial; Laboratory; and Molten Metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUBUNRBAAURAA
Date   Source Headline
14th Feb 201812:02 pmRNSPrice Monitoring Extension
13th Feb 20184:40 pmRNSSecond Price Monitoring Extn
13th Feb 20184:35 pmRNSPrice Monitoring Extension
1st Feb 20185:57 pmRNSBlock listing Interim Review
29th Jan 20187:00 amRNSResults for the year ended 30 November 2017
2nd Jan 201810:35 amRNSHolding(s) in Company
12th Dec 20174:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSPre-close Trading Update and Acquisition
6th Nov 20174:40 pmRNSSecond Price Monitoring Extn
6th Nov 20174:35 pmRNSPrice Monitoring Extension
18th Oct 20174:35 pmRNSPrice Monitoring Extension
13th Oct 201710:00 amRNSDirector's Shareholding and Issue of Equity
10th Oct 20178:27 amRNSHolding(s) in Company
3rd Oct 20174:35 pmRNSPrice Monitoring Extension
28th Sep 20177:00 amRNSAppointment of an Independent NED
19th Sep 20177:00 amRNSTrading Update
17th Aug 201711:34 amRNSHolding(s) in Company
28th Jun 201712:32 pmRNSDirector's Shareholding and Issue of Equity
27th Jun 20177:00 amRNSHalf Yearly Results
22nd Jun 201710:00 amRNSAdditional Listing
5th Jun 20177:00 amRNSTrading Update
11th Apr 201711:50 amRNSAGM resolutions
11th Apr 20177:00 amRNSAGM Statement and Trading Update
10th Apr 20174:51 pmRNSHolding(s) in Company
5th Apr 20177:00 amRNSAcquisition
24th Mar 20178:00 amRNSDirector's Shareholding and Issue of Equity
10th Mar 201712:05 pmRNSPosting of Accounts, AGM and Change of Auditor
22nd Feb 201710:33 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSResults for the year ended 30 November 2016
26th Jan 20174:12 pmRNSHolding(s) in Company
6th Dec 20167:00 amRNSTrading Update and Directorate Change
30th Nov 20168:21 amRNSDirector's shareholding and changes in equity
14th Nov 201610:28 amRNSDr Krishnamurthy Rajagopal
10th Nov 20165:09 pmRNSHolding(s) in Company
3rd Oct 20164:06 pmRNSHolding(s) in Company
3rd Oct 20164:04 pmRNSHolding(s) in Company
3rd Oct 201610:29 amRNSHolding(s) in Company
21st Sep 201612:07 pmRNSSecond Price Monitoring Extn
21st Sep 201612:02 pmRNSPrice Monitoring Extension
21st Sep 20169:28 amRNSHolding(s) in Company
21st Sep 20167:00 amRNSTrading update & appointment of an Independent NED
27th Jun 20167:00 amRNSHalf yearly results
16th Jun 20163:49 pmRNSHolding(s) in Company
16th Jun 20163:48 pmRNSHolding(s) in Company
16th Jun 201611:02 amRNSHolding(s) in Company
2nd Jun 20167:00 amRNSTrading Update
17th May 20163:19 pmRNSHolding(s) in Company
17th May 20163:18 pmRNSHolding(s) in Company
12th Apr 20162:51 pmRNSAGM resolutions
18th Mar 201612:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.